Global Blood Filter Market by Types (Whole Blood Transfusion, Red Cell Transfusion, and Platelet Transfusion), By Applications (Blood Processing and Blood Transfusion), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global blood filter market size was valued at USD 360 million in 2019 and is anticipated to surpass the market value of around USD 517.6 million by 2027. The market is projected to expand at a CAGR of 4.3% during the forecast period, 2021 – 2028. The growth of the market is attributed to increasing prevalence of chronic kidney disease and growing incidence of disorders that need blood transfusions such as sickle cell disease, anemia, bleeding disorders like hemophilia, or cancer.
Filtration methods used to remove microaggregates from donor blood are known as blood filters. These microaggregates are made up of platelets, leucocytes, and fibrin aggregates that cause pulmonary microembolism and other problems, if left in the donor blood. White blood cells (leukocytes) in donor blood inhibit the immune system of the receiver. In post-surgical patients, a reduced immune system effectively raises the risk of infection, multiple organ failure, and other problems, lowering the patient's survival rate. Furthermore, leucocytes contain several viruses including cytomegalovirus, Human T-cell Lymphotropic virus, Epstein-Barr virus, and bacteria such as Yersinia drastically reduce the chances of a patient's cure from some types of cancer.
Market Trends, Drivers, Restraints, and Opportunities:
Drivers
- Demand for blood transfusions is rapidly increasing, due to growing global disease burden and rising number of trauma cases. A blood transfusion is needed every three seconds. Rising number of incidents of trauma and road accidents around the world is propelling the blood filter market during the projected period.
- The global demand for surgical operations is increasing, as the aging population becomes sensitive to chronic diseases, which is projected to boost the market during the forecast period. In 2015, the geriatric population accounted for 8.5 percent of the global population, according to the International Population Report. Between 2025 and 2050, the geriatric population is expected to nearly double, reaching 1.6 billion.
- The number of people suffering from various chronic diseases is rapidly rising around the world. As a result, the number of surgical procedures is expected to increase, which is anticipated to drive the global blood filters market in the coming years.
Restraints
- High price and risk associated with the procedure of blood transfusion are projected to hinder the market growth during the forecast period.
Scope of the Report
The report on the global blood filter market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
Global Blood Filter Market Segment Insights:
Based on types, the market is divided into whole blood transfusion, red cell transfusion, and platelet transfusion. The platelet transfusion segment is expected to account for a key share of the market during the forecast. Platelets are a type of blood component that prevents the body from bleeding. As a result of chemotherapy treatments, patients with leukemia or other types of cancer frequently have reduced platelet counts. Rising prevalence of other types of cancer is expected to boost the platelet segment in the coming years. Patients with diseases that prevent the body from producing enough platelets require platelet transfusions regularly to stay healthy.
In terms of applications, the global blood filter market is divided into blood processing and blood transfusion. During the projected period, the blood transfusion market is predicted to continue its dominance with the growing number of road accidents and rising prevalence of kidney disease across the globe. Blood transfusions are a regular medical intervention. In the US, 21 million blood components are transfused each year. Patients with serious injuries as a result of car accidents or natural calamities are given blood transfusions. Blood transfusions are frequently given to those who have anemia and have illnesses such as leukemia or kidney disease.
On the basis of regions, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Rapid economic development in India, China, Brazil, South Africa, and other countries in Asia and Latin America increased healthcare spending, improved healthcare products such as blood filters, and made blood filters affordable. Increased hospitalization, due to rising incidence of heart illnesses and chronic diseases, is fueling the number of surgical procedures in the country. This is expected to drive the blood filters market during the forecast period.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Filter Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Filter Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Filter Market - Supply Chain
4.5. Global Blood Filter Market Forecast
4.5.1. Blood Filter Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Filter Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Blood Filter Market Absolute $ Opportunity
5. Global Blood Filter Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Blood Filter Market Size and Volume Forecast by Types
5.3.1. Whole Blood Transfusion
5.3.2. Red Cell Transfusion
5.3.3. Platelet Transfusion
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Blood Filter Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Blood Filter Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Blood Filter Demand Share Forecast, 2019-2026
7. North America Blood Filter Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Blood Filter Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Blood Filter Market Size and Volume Forecast by Types
7.4.1. Whole Blood Transfusion
7.4.2. Red Cell Transfusion
7.4.3. Platelet Transfusion
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Blood Filter Demand Share Forecast, 2019-2026
8. Latin America Blood Filter Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Blood Filter Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Blood Filter Market Size and Volume Forecast by Types
8.4.1. Whole Blood Transfusion
8.4.2. Red Cell Transfusion
8.4.3. Platelet Transfusion
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Blood Filter Demand Share Forecast, 2019-2026
9. Europe Blood Filter Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Blood Filter Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Blood Filter Market Size and Volume Forecast by Types
9.4.1. Whole Blood Transfusion
9.4.2. Red Cell Transfusion
9.4.3. Platelet Transfusion
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Blood Filter Demand Share Forecast, 2019-2026
10. Asia Pacific Blood Filter Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Blood Filter Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Blood Filter Market Size and Volume Forecast by Types
10.4.1. Whole Blood Transfusion
10.4.2. Red Cell Transfusion
10.4.3. Platelet Transfusion
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Blood Filter Demand Share Forecast, 2019-2026
11. Middle East & Africa Blood Filter Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Blood Filter Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Blood Filter Market Size and Volume Forecast by Types
11.4.1. Whole Blood Transfusion
11.4.2. Red Cell Transfusion
11.4.3. Platelet Transfusion
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Blood Filter Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Blood Filter Market: Market Share Analysis
12.2. Blood Filter Distributors and Customers
12.3. Blood Filter Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Asahi Kasei Medical Co., Ltd.
12.4.2. Haemonetics Corporation
12.4.3. Fresenius Kabi Deutschland GmbH
12.4.4. Macopharma
12.4.5. Shandong Zhongbaokang Medical Implements Co., Ltd.
12.4.6. Nanjing Shuangwei Biotechnology Co., Ltd.
12.4.7. Braile Biomédica
Segments Covered in the Report:
By Types
- Whole Blood Transfusion
- Red Cell Transfusion
- Platelet Transfusion
By Applications
- Blood Processing
- Blood Transfusion
By Regions
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
By Key players
- Asahi Kasei Medical Co., Ltd.
- Haemonetics Corporation
- Fresenius Kabi Deutschland GmbH
- Macopharma
- Shandong Zhongbaokang Medical Implements Co., Ltd.
- Nanjing Shuangwei Biotechnology Co., Ltd.
- Braile Biomédica
- Infomed SA
- Kaneka Pharma Europe NV
- Kawasumi Laboratories Inc.
- GVS S.p.A.
Key players operating in the global blood filter market are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Fresenius Kabi Deutschland GmbH, Macopharma, Shandong Zhongbaokang Medical Implements Co., Ltd., Nanjing Shuangwei Biotechnology Co., Ltd., Braile Biomédica, Infomed SA, Kaneka Pharma Europe NV, Kawasumi Laboratories Inc., and GVS S.p.A.
Our Clients
Related Reports
Some other reports from this category!
